Indian Drugmaker Cited for Numerous Violations

An FDA inspection of drugmaker Goran Pharma in November netted the company a Form 483 with 17 observations ranging from inadequate employee training to laboratory deficiencies and contamination risks.
Source: Drug Industry Daily